184 related articles for article (PubMed ID: 37296410)
41. Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial.
Zhu W; Cao Y; Ye M; Huang H; Wu Y; Ma J; Dong Y; Liu X; Liu C; Lip GYH
Thromb Haemost; 2023 Jan; 123(1):85-96. PubMed ID: 36037830
[TBL] [Abstract][Full Text] [Related]
42. Sex Differences in Heart Failure With Preserved Ejection Fraction.
Sotomi Y; Hikoso S; Nakatani D; Mizuno H; Okada K; Dohi T; Kitamura T; Sunaga A; Kida H; Oeun B; Sato T; Komukai S; Tamaki S; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Yasumura Y; Yamada T; Sakata Y;
J Am Heart Assoc; 2021 Feb; 10(5):e018574. PubMed ID: 33619973
[TBL] [Abstract][Full Text] [Related]
43. Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial.
Dong B; Yao Y; Xue R; Liang W; He J; Wei F; Dong Y; He X; Liu C
BMC Med; 2022 Nov; 20(1):423. PubMed ID: 36324141
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
[TBL] [Abstract][Full Text] [Related]
45. Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis.
Antlanger M; Aschauer S; Kopecky C; Hecking M; Kovarik JJ; Werzowa J; Mascherbauer J; Genser B; Säemann MD; Bonderman D
Kidney Blood Press Res; 2017; 42(1):165-176. PubMed ID: 28395286
[TBL] [Abstract][Full Text] [Related]
46. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
[TBL] [Abstract][Full Text] [Related]
47. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
49. Clinical characteristics and long-term clinical outcomes of Japanese heart failure patients with preserved versus reduced left ventricular ejection fraction: a prospective cohort of Shinken Database 2004-2011.
Kaneko H; Suzuki S; Yajima J; Oikawa Y; Sagara K; Otsuka T; Matsuno S; Kano H; Uejima T; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
J Cardiol; 2013 Aug; 62(2):102-9. PubMed ID: 23731923
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of tPA/PAI-1 complex in patients with heart failure and preserved ejection fraction.
Winter MP; Kleber ME; Koller L; Sulzgruber P; Scharnagl H; Delgado G; Goliasch G; März W; Niessner A
Thromb Haemost; 2017 Feb; 117(3):471-478. PubMed ID: 27975104
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.
Sun LY; Tu JV; Bader Eddeen A; Liu PP
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401
[TBL] [Abstract][Full Text] [Related]
52. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions.
Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T;
Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996
[TBL] [Abstract][Full Text] [Related]
53. Phenotyping of Elderly Patients With Heart Failure Focused on Noncardiac Conditions: A Latent Class Analysis From a Multicenter Registry of Patients Hospitalized With Heart Failure.
Nakamaru R; Shiraishi Y; Niimi N; Kohno T; Nagatomo Y; Takei M; Ikoma T; Nishikawa K; Sakamoto M; Nakano S; Kohsaka S; Yoshikawa T
J Am Heart Assoc; 2023 Feb; 12(3):e027689. PubMed ID: 36695300
[TBL] [Abstract][Full Text] [Related]
54. Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
Binnenmars SH; Hoogslag GE; Yeung SMH; Brouwers FP; Bakker SJL; van Gilst WH; Gansevoort RT; Navis G; Voors AA; de Borst MH
J Am Heart Assoc; 2022 Aug; 11(15):e024952. PubMed ID: 35876420
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
56. Comparison of Effects of Statin Use on Mortality in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
Lee MS; Duan L; Clare R; Hekimian A; Spencer H; Chen W
Am J Cardiol; 2018 Aug; 122(3):405-412. PubMed ID: 30201108
[TBL] [Abstract][Full Text] [Related]
57. Prognostic relevance of elevated plasma osmolality on admission in acute decompensated heart failure with preserved ejection fraction: insights from PURSUIT-HFpEF registry.
Nakagawa A; Yasumura Y; Yoshida C; Okumura T; Tateishi J; Yoshida J; Tamaki S; Yano M; Hayashi T; Nakagawa Y; Yamada T; Nakatani D; Hikoso S; Sakata Y;
BMC Cardiovasc Disord; 2021 Jun; 21(1):281. PubMed ID: 34098878
[TBL] [Abstract][Full Text] [Related]
58. Effect of Cigarette Smoking on Risk for Adverse Events in Patients With Heart Failure and Preserved Ejection Fraction.
Sandesara PB; Samman-Tahhan A; Topel M; Venkatesh S; O'Neal WT
Am J Cardiol; 2018 Aug; 122(3):400-404. PubMed ID: 30201107
[TBL] [Abstract][Full Text] [Related]
59. Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction.
Nishino M; Egami Y; Kawanami S; Sugae H; Ukita K; Kawamura A; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Matsunaga-Lee Y; Yano M; Tanouchi J; Yamada T; Yasumura Y; Tamaki S; Hayashi T; Nakagawa A; Nakagawa Y; Sotomi Y; Nakatani D; Hikoso S; Sakata Y;
J Am Heart Assoc; 2022 Oct; 11(19):e026301. PubMed ID: 36129035
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
